Loading
BranchLab is an AI-native technology company founded in 2024, dedicated to transforming healthcare commercialization. The company offers a privacy-first platform that connects pharmaceutical brands, agencies, and media partners with patients and providers, facilitating access to life-improving therapies without using individual-level health information. Based in New York, with additional offices in San Francisco, Boulder, and Seattle, BranchLab's primary product is the Pathwai™ platform. This comprehensive solution enables the design, activation, and measurement of audiences based on real-world outcomes, utilizing non-health or demographic data. The company also features HealthGraph™, a database with anonymized data on over 300 million patients and 2.1 million healthcare providers, and employs advanced cleanroom technology to ensure data security and compliance. BranchLab serves a variety of clients in the healthcare advertising sector, including pharmaceutical brands, agencies, direct-to-consumer marketers, healthcare professional marketers, and publishers. The company has raised $35 million in funding, with a focus on driving measurable outcomes while prioritizing transparency and privacy.